• New Leaf Ventures Inc. (NLV) has launched a new nation-wide CBD-only product line under its highly popular premier Dama Brand
  • The company’s flagship Dama Brand product team today announced extensive plans for entry into the growing CBD marketplace
  • The proposed lineup will feature herbal blend tinctures, soft gels, and topicals
  • These proposed high-quality hemp products will benefit from a nation-wide rollout launching in Q1 2021
  • New Leaf Ventures Inc. is up 7.69 per cent to C$0.70 per share

New Leaf Ventures Inc. (NLV) has launched a new nationwide CBD-only product line under its highly popular premier Dama Brand.

The company’s Dama Brand product team has announced plans for entry into the growing CBD marketplace. The proposed lineup will feature herbal blend tinctures, soft gels, and topicals.

These proposed high-quality hemp products will benefit from a nationwide rollout launching in Q1 2021. The new products will be marketed directly to consumers through an e-commerce platform and wholesaled to multi-outlet grocery and pharmacy retailers.

With growing global consumer interest in the CBD market, particular emphasis on source-origin and attention to high-grade cultivation and premium nutrient inputs are paramount to meeting the criteria of well-informed health-conscious individuals.

New Leaf Ventures brings decades of extensive cannabis industry knowledge to understand and choose the best formulations. The team’s passion for the healing properties of the hemp plant brings great pride and excitement to supply consumers not only in Washington but across the entire United States.

New Leaf USA and Director of New Leaf Ventures Inc. CEO Dax Colwell said the CBD market is evolving and expanding.

“We can educate consumers about the benefits of different cannabinoids and holistic plant science with a trusted, safe, effective product.”

In November of last year, New Leaf announced the development of a CBD beverage, and this latest project will round out and extend the overall product offering to retailers and consumers alike.

The company’s commitment to CBD extends co-founder Dax Colwell’s personal vision. He has been a champion of CBD since he launched ‘Leaf of Hope’ in November 2013 for 30 families that provided at-risk children with a CBD-rich strain of cannabis known as AC/DC.

Children in the program ranged in age from 3-20, most of whom are suffering from intractable epilepsy diagnoses. The results from the program were incredibly positive, seeing a reduction in seizure frequency in addition to tremendous quality of life improvements.

CBD is a non-psychoactive cannabinoid, native to Cannabis. Hemp products are classified through the FDA as containing less than .3 per cent THC.

Mounting scientific evidence is supporting the anecdotal efficacy of CBD regarding a host of disorders. Products will include plant based herbal formulations designed for wellness, balance, reduction of stress, and body tension.

New Leaf Ventures Inc. is developing a cannabis sector-based scalable securities concept of focused financing and applied management to achieve earnings growth through targeted investment.

New Leaf Ventures Inc. is up 7.69 per cent to C$0.70 per share.

More From The Market Online
Cannabis Report text across cannabis leaves.

StockTalk | Cannabis Report: The Holiday Edition

MediPharm Labs has signed a share purchase agreement with Kensana Health for the purchase and sale of its facility in Napanee, Ontario.
Cannabis Report in text over top a photo of cannabis leaves

StockTalk | Cannabis Report: A new Canadian cannabis king crowned

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks
Man in cannabis field

Cannabis-based autism drug shines in phase-1 testing

Charlotte's Web (TSX:CWEB) announces positive results from a phase-1 dose trial of AJA001, its cannabis-based autism treatment.
File image of a snow drift

Buzz on the Bullboards: Feeling holiday blues, or celebrating blue chip stocks?

Some shareholders have enjoyed early holiday gifts in the form of rising stock prices, while others have faced disappointments.